CLARUS THERAPEUTICS HOLDINGS (CRXT)

US18271L1070 - Common Stock

0.099  -0.06 (-36.94%)

After market: 0.101 +0 (+2.02%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
16.91M13.96M6.37M0.00
Cost Of Goods
3.62M2.72M8.69M0.00
Gross Profit
13.29M11.24M-2.32M0.00
Operating Expenses
53.19M50.97M44.86M17.88M
Research and Development
3.92M3.63M3.41M3.09M
Selling, General, and Administrative Expenses
49.27M47.34M41.45M14.79M
Operating Income
-39.90M-39.73M-47.18M-17.88M
Interest Income/Expense
-10.36M-15.89M-15.37M-23.79M
Other Income/Expense
13.88M12.51M66.89M13.00K
Non Recurring Items
N/A2.50MN/AN/A
Income Before Taxes
-32.63M-40.62M4.34M-41.65M
Income Tax
N/A0.000.000.00
Net Income
-32.63M-40.62M4.34M-41.65M
EBITDA
N/A-39.71M-47.16M-17.87M
 
Per Share Data
EPS Diluted Total Ops
-1.12-1.690.20-1.92
Non GAAP EPS
-1.27N/AN/AN/A
 
Statistics
Gross Profit Margin
78.57%80.51%-36.40%N/A
Profit Margin
-193.00%-291.02%68.22%N/A
Operating Profit Margin
-235.99%-284.67%-740.73%N/A

All data in USD

Charts